Trails Edge Capital Partners, LP / XENE
Trails Edge Capital Partners, LP’s Xenon Pharmaceuticals Inc Position
Does Trails Edge Capital Partners, LP own Xenon Pharmaceuticals Inc (XENE)? Yes — 440.0K shares worth $26M (+5.86% of its 13F portfolio) as of Q1 2026, down from 597.1K shares the prior filed quarter.
Position Value
$26M
Q1 2026
Shares
440.0K
% of Portfolio
+5.86%
Quarters Held
2
currently held
Position History XENE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of XENE.